Increased expression of SARS-CoV2 entry receptor ACE-2, furin, and protease TMPRSS2 was observed in liver tissue of NAFLD patients (Meijnikman et al., 2020). The gene discussed is ACE2; the disease is metabolic dysfunction-associated steatotic liver disease.